TransMedics (TMDX) Non-Current Debt (2018 - 2026)

TransMedics' Non-Current Debt history runs 9 years deep, the most recent figure standing at $44.7 million for Q1 2026.

• On a quarterly basis, Non-Current Debt fell 24.87% year-over-year to $44.7 million in Q1 2026; TTM through Mar 2026 was $44.7 million, a 24.87% decrease from a year earlier, with the FY2025 full-year figure at $49.6 million, down 16.48% from the prior year.
• Non-Current Debt eased to $44.7 million in Q1 2026 per TMDX's latest filing, from $49.6 million in the prior quarter.
• Across five years, Non-Current Debt topped out at $59.5 million in Q2 2025 and bottomed at $35.3 million in Q1 2022.
• The 5-year median for Non-Current Debt is $58.9 million (2023), against an average of $54.6 million.
• Across the five-year window, Non-Current Debt jumped 66.98% in 2022 and decreased 24.87% in 2026, its largest moves.
• Year by year, Non-Current Debt stood at $58.7 million in 2022, then rose by 0.63% to $59.1 million in 2023, then rose by 0.52% to $59.4 million in 2024, then declined by 16.48% to $49.6 million in 2025, then dropped by 9.93% to $44.7 million in 2026.
• Per Business Quant, the three latest TMDX Non-Current Debt figures stand at $44.7 million (Q1 2026), $49.6 million (Q4 2025), and $54.6 million (Q3 2025).